Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
27
Filosofía
14
Libre albedrío y determinismo
10
Jazz
9
Música popular
9
Aspectos económicos
8
Sociología
8
Etnología
7
Comercio
6
Aspectos psicológicos
5
Aspectos sociales
5
Cambio social
5
Ciudades y pueblos
5
Libre comercio
5
Modelos matemáticos
5
Política económica
5
Política gubernamental
5
Abuso de drogas
4
Administración
4
Ciencias sociales
4
Condiciones sociales
4
Democracia
4
Educación
4
Filosofía de la mente
4
History
4
Inglés
4
Mercadotecnia
4
Política y gobierno
4
Sistemas operativos (Computadoras)
4
Urbanismo
4
-
486001“…Size metrics investigated were total body weight, fat and fat-free mass. Theory-based allometry was used to scale pharmacokinetic parameters to a 70 kg individual. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486002por Borde, Julika, Laitman, Yael, Blümcke, Britta, Niederacher, Dieter, Weber-Lassalle, Konstantin, Sutter, Christian, Rump, Andreas, Arnold, Norbert, Wang-Gohrke, Shan, Horváth, Judit, Gehrig, Andrea, Schmidt, Gunnar, Dutrannoy, Véronique, Ramser, Juliane, Hentschel, Julia, Meindl, Alfons, Schroeder, Christopher, Wappenschmidt, Barbara, Engel, Christoph, Kuchenbaecker, Karoline, Schmutzler, Rita K., Friedman, Eitan, Hahnen, Eric, Ernst, Corinna“…Here we assess the contribution of polygenic risk scores (PRSs) to the occurrence of extreme phenotypes with respect to age at onset, namely, primary BC diagnosis before the age of 35 years (early diagnosis, ED) and cancer-free survival until the age of 60 years (late/no diagnosis, LD) in female BRCA1/2 PV carriers. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486003por Bhadhuri, Arjun, Dröschel, Daniel, Guldimann, Mike, Jetschgo, Claudia, Banhazi, Judit, Schwenkglenks, Matthias, Sutherland, C. Simone“…RESULTS: For the base-case, VN resulted in incremental costs per patient of CHF 764’402 (VN: CHF 901’654, SoC: CHF 137’252), incremental blindness-free years of 7.67 (VN: 28.32, SoC: 20.65) and incremental QALYs of 6.73 (VN: 18.35, SoC: 11.62), leading to an incremental cost-effectiveness ratio of CHF 113’526 per QALY gained. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486004por Chen, Hua‐Lin, Luo, Yi‐Ping, Lin, Mu‐Wen, Peng, Xiao‐Xia, Liu, Mei‐Liang, Wang, Yong‐Cun, Li, Shu‐Jun, Yang, Dong‐Hong, Yang, Zhi‐Xiong“…In addition, the overall survival (OS) and progression‐free survival (PFS) rates among PD‐L1 inhibitor managed sufferers were acquired through a follow‐up visit. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486005por Zou, Shi, Wu, Mengmeng, Ming, Fangzhao, Wu, Songjie, Guo, Wei, Marley, Gifty, Xing, Zhongyuan, Zhang, Zhiyue, Zeng, Minxia, Sun, Chao, Zhang, Jianfeng, Tang, Weiming, Liang, Ke“…Although current guidelines encourage people living with HIV (PLWH) to take COVID-19 vaccines, whether their immune response to COVID-19 vaccines is distinct from HIV-free individuals is still unclear. METHODS: Between March to June 2021, 48 PLWH and 40 HNC, aged 18 to 59 years, were enrolled in the study in Wuchang district of Wuhan city. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486006“…Separation of leukocytes and cell-free supernatant of a bronchoalveolar lavagate by centrifugation revealed that carbon black was completely located in the cell sediment, indicating total engulfment by alveolar macrophages. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486007por Ang, Bryan Chin Hou, Chiew, Wenqi, Yip, Vivien Cherng Hui, Chua, Chun Hau, Han, Wei Shan, Tecson, Ivan O’Neill C., Ogle, Jeanne Joyce, Lim, Boon Ang, Hee, Owen Kim, Tay, Elton Lik Yong, Yong, Vernon Khet Yau, Wong, Hon Tym, Yip, Leonard Wei Leon“…By POM12, 25 (83.3%) eyes were medication-free. Three (10%) eyes had stent occlusion by iris requiring laser iridoplasty. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486008por Bhave, Prachi, Ahmed, Tasnia, Lo, Serigne N, Shoushtari, Alexander, Zaremba, Anne, Versluis, Judith M, Mangana, Joanna, Weichenthal, Michael, Si, Lu, Lesimple, Thierry, Robert, Caroline, Trojanello, Claudia, Wicky, Alexandre, Heywood, Richard, Tran, Lena, Batty, Kathleen, Dimitriou, Florentia, Stansfeld, Anna, Allayous, Clara, Schwarze, Julia K, Mooradian, Meghan J, Klein, Oliver, Mehmi, Inderjit, Roberts-Thomson, Rachel, Maurichi, Andrea, Yeoh, Hui-Ling, Khattak, Adnan, Zimmer, Lisa, Blank, Christian U, Ramelyte, Egle, Kähler, Katharina C, Roy, Severine, Ascierto, Paolo A, Michielin, Olivier, Lorigan, Paul C, Johnson, Douglas B, Plummer, Ruth, Lebbe, Celeste, Neyns, Bart, Sullivan, Ryan, Hamid, Omid, Santinami, Mario, McArthur, Grant A, Haydon, Andrew M, Long, Georgina V, Menzies, Alexander M, Carlino, Matteo S“…Primary outcome was objective response rate (ORR); secondary outcomes were progression-free survival (PFS) and overall survival (OS). RESULTS: In total, 325 patients were included: 234 (72%) plantar, 69 (21%) subungual and 22 (7%) palmar primary sites. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486009por Zhao, Wan-Hong, Wang, Bai-Yan, Chen, Li-Juan, Fu, Wei-Jun, Xu, Jie, Liu, Jie, Jin, Shi-Wei, Chen, Yin-Xia, Cao, Xing-Mei, Yang, Yun, Zhang, Yi-Lin, Wang, Fang-Xia, Zhang, Peng-Yu, Lei, Bo, Gu, Liu-Fang, Wang, Jian-Li, Zhang, Hui, Bai, Ju, Xu, Yan, Zhu, Han, Du, Juan, Jiang, Hua, Fan, Xiao-Hu, Li, Jian-Yong, Hou, Jian, Chen, Zhu, Zhang, Wang-Gang, Mi, Jian-Qing, Chen, Sai-Juan, He, Ai-Li“…The median progression-free survival was 18.0 months, and the median overall survival for all patients was not reached. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486010por Heileson, Jeffery L., McGowen, Jared M., Moris, Jose M., Chapman-Lopez, Tomas J., Torres, Ricardo, Funderburk, LesLee K., Forsse, Jeffrey S.“…METHODS: Sixty cadets (43 males, 17 females; 20.9 ± 3.8 years; 173.6 ± 10.2 cm; 75.6 ± 13.7 kg) completed the 6-event ACFT (3-repetition maximum trap-bar deadlift [3DL], standing power toss [SPT], hand-release pushups [HRPU], sprint-drag-carry shuttle run [SDC], leg tuck [LTK], or plank [PLK], and 2-mile run [2MR]), body composition analysis via dual-energy x-ray absorptiometry (percent body fat [%BF], lean body mass [LBM], fat-free mass index [FFMI (LBM+bone mineral content)]), and an omega-3 questionnaire. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486011por Pires da Silva, Ines, Zakria, Danny, Ahmed, Tasnia, Trojanello, Claudia, Dimitriou, Florentia, Allayous, Clara, Gerard, Camille, Zimmer, Lisa, Lo, Serigne, Michielin, Olivier, Lebbe, Celeste, Mangana, Johanna, Ascierto, Paolo Antonio, Johnson, Douglas B, Carlino, Matteo, Menzies, Alexander, Long, Georgina“…BACKGROUND: Patients with V600BRAF mutant metastatic melanoma have higher rates of progression-free survival (PFS) and overall survival (OS) with first-line anti-PD1 (PD1]+anti-CTLA-4 (IPI) versus PD1. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486012“…Wechat public platform has built a bridge for communication between teachers and students and realized free dialogue between teachers and students. Therefore, the platform has become an oral English training base. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486013por Yu, Edward, Allan, Alison L., Sanatani, Michael, Lewis, Debra, Warner, Andrew, Dar, A. Rashid, Yaremko, Brian P., Lowes, Lori E., Palma, David A., Raphael, Jacques, Vincent, Mark D., Rodrigues, George B., Fortin, Dalilah, Inculet, Richard I., Frechette, Eric, Bierer, Joel, Law, Jeffery, Younus, Jawaid, Malthaner, Richard A.“…Detection of CTCs at any follow-up visit was significantly predictive of worse disease-free survival (DFS;hazard ratio [HR]: 2.44; 95% confidence interval [CI]: 1.41-4.24; p=0.002), regional control (HR: 6.18; 95% CI: 1.18-32.35; p=0.031), distant control (HR: 2.93; 95% CI: 1.52-5.65;p=0.001) and overall survival (OS;HR: 2.02; 95% CI: 1.16-3.51; p=0.013). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486014“…The optimized strategy was further used to compare the phosphoproteomes of the lung cancer cells with different metastatic abilities. Label-free quantification proteomics demonstrated that 510, 863, and 1108 phosphorylated proteins were identified from normal lung fibroblasts (MRC-5), low metastatic lung cancer cells (95C), and high metastatic lung cancer cells (95D), respectively, using the optimized Ti(4+)-IMAC method. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486015por Hua, Tong, Yang, Mei, Song, Honghao, Kong, Erliang, Deng, Mengqiu, Li, Yongchang, Li, Jian, Liu, Zhixiao, Fu, Hailong, Wang, Yue, Yuan, Hongbin“…In recent years, human umbilical cord mesenchymal stem cells (huc-MSCs)-derived exosomes have been used to relieve neuropathic pain and other inflammatory diseases as a promising cell-free therapeutic strategy. However, the therapeutic value of huc-MSCs-derived exosomes in complete Freund's adjuvant (CFA)-induced inflammatory pain remains to be confirmed. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486016por Ward, Sarah V., Burton, Anya, Tamimi, Rulla M., Pereira, Ana, Garmendia, Maria Luisa, Pollan, Marina, Boyd, Norman, dos-Santos-Silva, Isabel, Maskarinec, Gertraud, Perez-Gomez, Beatriz, Vachon, Celine, Miao, Hui, Lajous, Martín, López-Ridaura, Ruy, Bertrand, Kimberly, Kwong, Ava, Ursin, Giske, Lee, Eunjung, Ma, Huiyan, Vinnicombe, Sarah, Moss, Sue, Allen, Steve, Ndumia, Rose, Vinayak, Sudhir, Teo, Soo-Hwang, Mariapun, Shivaani, Peplonska, Beata, Bukowska-Damska, Agnieszka, Nagata, Chisato, Hopper, John, Giles, Graham, Ozmen, Vahit, Aribal, Mustafa Erkin, Schüz, Joachim, Van Gils, Carla H., Wanders, Johanna O. P., Sirous, Reza, Sirous, Mehri, Hipwell, John, Kim, Jisun, Lee, Jong Won, Dickens, Caroline, Hartman, Mikael, Chia, Kee-Seng, Scott, Christopher, Chiarelli, Anna M., Linton, Linda, Flugelman, Anath Arzee, Salem, Dorria, Kamal, Rasha, McCormack, Valerie, Stone, Jennifer“…METHODS: Participants were 10,681 breast-cancer-free women from 22 countries in the International Consortium of Mammographic Density, each with centrally assessed mammographic density and a common set of epidemiologic data. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486017por Guberina, Nika, Pöttgen, Christoph, Schuler, Martin, Guberina, Maja, Stamatis, Georgios, Plönes, Till, Metzenmacher, Martin, Theegarten, Dirk, Gauler, Thomas, Darwiche, Kaid, Aigner, Clemens, Eberhardt, Wilfried E. E., Stuschke, Martin“…Endpoints were overall-survival (OS), progression-free-survival (PFS), and cumulative incidences of isolated loco-regional failures, distant metastases, secondary tumors as well as non-cancer deaths within the first year. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486018por Fallah, Aria, Lewis, Evan, Ibrahim, George M., Kola, Olivia, Tseng, Chi‐Hong, Harris, William B., Chen, Jia‐Shu, Lin, Kao‐Min, Cai, Li‐Xin, Liu, Qing‐Zhu, Lin, Jiu‐Luan, Zhou, Wen‐Jing, Mathern, Gary W., Smyth, Matthew D., O'Neill, Brent R., Dudley, Roy W. R., Ragheb, John, Bhatia, Sanjiv, Delev, Daniel, Ramantani, Georgia, Zentner, Josef, Wang, Anthony C., Dorfer, Christian, Feucht, Martha, Czech, Thomas, Bollo, Robert J., Issabekov, Galymzhan, Zhu, Hongwei, Connolly, Mary, Steinbok, Paul, Zhang, Jian‐Guo, Zhang, Kai, Hidalgo, Eveline Teresa, Weiner, Howard L., Wong‐Kisiel, Lily, Lapalme‐Remis, Samuel, Tripathi, Manjari, Sarat Chandra, Poodipedi, Hader, Walter, Wang, Feng‐Peng, Yao, Yi, Champagne, Pierre‐Olivier, Brunette‐Clément, Tristan, Guo, Qiang, Li, Shao‐Chun, Budke, Marcelo, Pérez‐Jiménez, Maria Angeles, Raftopoulos, Christian, Finet, Patrice, Michel, Pauline, Schaller, Karl, Stienen, Martin N., Baro, Valentina, Cantillano Malone, Christian, Pociecha, Juan, Chamorro, Noelia, Muro, Valeria L., von Lehe, Marec, Vieker, Silvia, Oluigbo, Chima, Gaillard, William D., Al‐Khateeb, Mashael, Al Otaibi, Faisal, Krayenbühl, Niklaus, Bolton, Jeffrey, Pearl, Phillip L., Weil, Alexander G.“…Log‐rank test found that vertical hemispherotomy was associated with durable seizure‐free progression compared to the lateral approach (p = .01). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486019por Xia, Dongdong, Bai, Wei, Wang, Enxin, Li, Jiaping, Chen, Xiaoming, Wang, Zhexuan, Huang, Mingsheng, Huang, Ming, Sun, Junhui, Yang, Weizhu, Lin, Zhengyu, Wu, Jianbing, Li, Zixiang, Yang, Shufa, Zhu, Xu, Chen, Zaizhong, Zhang, Yanfang, Fan, Wenzhe, Mai, Qicong, Ding, Rong, Nie, Chunhui, Feng, Long, Li, Xueda, Huang, Wukui, Sun, Jun, Wang, Qiuhe, Lv, Yong, Li, Xiaomei, Luo, Bohan, Wang, Zhengyu, Yuan, Jie, Guo, Wengang, Li, Kai, Li, Bing, Li, Ruijun, Yin, Zhanxin, Xia, Jielai, Han, Guohong“…Overall survival (OS), progression-free survival (PFS), objective response rate (ORR) were evaluated by modified Response Evaluation Criteria in Solid Tumors criteria, and safety profiles were compared between the two groups. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
486020por Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke, Tsumura, Hidetaka, Kuzuya, Teiji, Isoda, Norio, Moriguchi, Michihisa, Aino, Hajime, Ido, Akio, Kawabe, Naoto, Nakao, Kazuhiko, Wada, Yoshiyuki, Ogasawara, Sadahisa, Yoshimura, Kenichi, Okusaka, Takuji, Furuse, Junji, Kokudo, Norihiro, Okita, Kiwamu, Johnson, Philip James, Arai, Yasuaki“…INTRODUCTION: Several clinical trials comparing the efficacy and safety of transarterial chemoembolization (TACE) plus molecular-targeted agents versus TACE alone revealed no clinical benefits in progression-free survival (PFS) or overall survival (OS). Here, we report the final OS analysis from the TACTICS trial, which previously demonstrated significant improvement in PFS with TACE plus sorafenib in patients with unresectable hepatocellular carcinoma (HCC) (NCT01217034). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto